Zenapax

In the US, Zenapax (daclizumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Organ Transplant - Rejection Prophylaxis and Rheumatoid Arthritis.

US matches:

• Zenapax

Ingredient matches for Zenapax

Daclizumab

Daclizumab is reported as an ingredient of Zenapax in the following countries:

• Argentina


• Belarus


• Brazil


• Canada


• Chile


• Colombia


• Croatia (Hrvatska)


• Denmark


• Ecuador


• Estonia


• Greece


• Hong Kong


• India


• Iran


• Israel


• Macedonia


• Mexico


• New Zealand


• Oman


• Pakistan


• Peru


• Philippines


• Russian Federation


• Serbia


• Singapore


• Slovenia


• South Africa


• South Korea


• Sri Lanka


• Taiwan


• Thailand


• Turkey


• Ukraine


• United States


• Uruguay


• Venezuela

International Drug Name Search